资产出售
Search documents
丽新发展附属拟出售Surearn Profits的全部已发行股份
Zhi Tong Cai Jing· 2025-12-09 15:04
Group 1 - The core transaction involves the sale of shares in Surearn Profits, which holds a 50% interest in Wah Lee, by a wholly-owned subsidiary of Lisheng Development to Jasmine Investment Development IV Limited [1] - The sale is part of a broader strategy to enhance the financial position of Lisheng Garment Group and Lisheng Development Group, with an estimated net cash inflow of approximately HKD 2.4 billion [2] - The agreed property value for the transaction is HKD 3.498 billion, which will be combined with the net asset value of Surearn Profits at completion [2] Group 2 - As of July 31, 2025, Lisheng Garment Group and Lisheng Development Group had net current liabilities of HKD 5.42 billion and HKD 4.506 billion, respectively [2] - The refinancing of the syndicated loan for Cheung Sha Wan Plaza is expected to be completed by September 30, 2025, which will further improve the financial metrics of both groups [2] - Upon completion of the sale, both groups are projected to shift from net current liabilities to net current assets [2]
丽新发展(00488)附属拟出售Surearn Profits的全部已发行股份
智通财经网· 2025-12-09 15:01
Group 1 - The core transaction involves the sale of shares in Surearn Profits, which holds a 50% interest in Wah Lee, by a subsidiary of Lishin Development to Jasmine Investment Development IV Limited, with completion expected on December 9, 2025 [1] - The sale includes all rights and interests associated with the shares, and the seller will facilitate the liquidation and distribution of the property according to Wah Lee's shareholding [1] - After the completion of the transaction, the seller will no longer hold any interest in the SPL property or Surearn Profits [1] Group 2 - The agreed price for the transaction is based on the property value of HKD 3.498 billion and the net asset value of Surearn Profits at completion [2] - The expected net cash inflow from the transaction is approximately HKD 2.4 billion, which will enhance the financial position of Lishin Garment Group and Lishin Development Group by increasing cash flow and reducing loans [2] - As of July 31, 2025, the net current liabilities for Lishin Garment Group and Lishin Development Group were HKD 5.42 billion and HKD 4.506 billion, respectively, and the transaction is expected to shift them to net current assets [2]
股价逼近跌停!中国中冶超600亿卖资产:有的近半价“甩卖”
Mei Ri Jing Ji Xin Wen· 2025-12-09 03:25
Core Viewpoint - China Metallurgical Group Corporation (China MCC) announced a plan to sell multiple assets, including real estate and non-ferrous mineral design and development, with a total transaction value of 60.68 billion yuan [1][2]. Asset Sale Details - The assets for sale include 100% equity and related debts of China MCC's subsidiaries, such as China MCC Real Estate Group, China Nonferrous Engineering Corporation, and others, totaling a transaction value of 60.68 billion yuan [1][2][5]. - The sale is part of an internal resource integration within the state-owned enterprise, with the buyer being China Minmetals Corporation and its affiliates [1]. Market Reaction - Following the announcement, China MCC's A-shares opened lower, approaching the daily limit down, while its Hong Kong shares fell over 20% [1][2]. Valuation Insights - The transaction price for China MCC Real Estate is set at 31.24 billion yuan, with an assessment showing a significant impairment rate of 45.18% due to declining market value [3][4]. - In contrast, the 100% equity of Huaye Duda Mining, held by China MCC, has a book value of 186 million yuan but an assessed value of 1.657 billion yuan, reflecting a substantial increase of 789.57% [4]. Financial Implications - The funds from the asset sale will primarily support the company's diversified business system, focusing on core metallurgical construction, new industrialization, and urbanization [8]. - Additionally, part of the proceeds will be used to enhance cash flow, repay debts, and optimize the financial structure [8].
证券代码:688469 证券简称:芯联集成 公告编号2025-064
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-12-09 03:17
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性依法承担法律责任。 一、已披露的拟对外出售资产暨关联交易概述 芯联集成电路制造股份有限公司(以下简称"公司"、"芯联集成")在芯片实验室检测领域深耕数年,在 硬件设施、实验设备、软件、技术、资质、经验和人员等方面有了丰富的积累。为了更好的服务客户, 扩大检测收入,优化产品结构,公司控股子公司芯联先锋集成电路制造(绍兴)有限公司(以下简 称"芯联先锋")与临港新片区基金设立合资公司上海芯港联测半导体有限责任公司(以下简称"芯港联 测"、"受让方")。合资公司注册资本人民币40,000.00万元,芯联先锋使用自有资金出资人民币 20,000.00万元,占注册资本总额50.00%。为快速推动项目的建设,实现合资公司业务的独立开展,公 司及公司子公司将持有的检测业务设备、专利及非专利型专有技术转让给芯港联测。公司于2025年9月 12日、2025年9月29日分别召开第二届董事会第八次会议和2025年第二次临时股东大会,审议通过了 《关于拟对外出售资产暨关联交易的议案》。具体内容详见公司于2025年9月1 ...
股价逼近跌停!央企内部整合大动作,从地产到矿山,中国中冶超600亿元卖资产:有的近半价“甩卖”,有的上千倍溢价转让
Mei Ri Jing Ji Xin Wen· 2025-12-09 02:39
Core Viewpoint - China Metallurgical Group Corporation (China MCC) plans to sell multiple assets, including real estate and non-ferrous mineral design and development, for a total consideration of 606.76 billion yuan, with the buyer being its controlling shareholder, China Minmetals Corporation and its affiliates [1][3]. Group 1: Asset Sale Details - The asset sale includes 100% equity and related debts of China MCC's subsidiaries, such as China MCC Real Estate Group, China Nonferrous Engineering Corporation, and others, with the total transaction price reaching 606.76 billion yuan [3][5]. - The transaction price for China MCC Real Estate is set at 312.37 billion yuan, with an assessment impairment rate of 45.18% due to a decline in market value [3][4]. - The sale of Huaye Duda Mining Co., which has a book value of 186 million yuan, shows a significant increase in assessed value to 1.657 billion yuan, reflecting a growth rate of 789.57% [4][5]. Group 2: Financial Implications - The transaction is expected to inject substantial funds into China MCC, which will be used to strengthen its core metallurgy construction business and support its diversified business system [8]. - The funds will be allocated to enhance new industrialization and urbanization, develop engineering services, new materials, high-end equipment, energy conservation, and digital applications [8]. - Part of the proceeds will also be used to improve cash flow and repay debts, optimizing the financial structure and reducing leverage [8].
A股重磅!660亿巨头拟甩卖607亿元资产
2 1 Shi Ji Jing Ji Bao Dao· 2025-12-09 01:47
截至12月8日收盘,中国中冶股价为3.39元,市值为667亿元。 12月8日晚,中国中冶公告(601618.SH)称,公司拟将所持有的中冶置业100%股权及对中冶置业的标的 债权,有色院、中冶铜锌、瑞木管理100%股权,中冶金吉67.02%股权,以及华冶杜达100%股权出售给 五矿地产控股和中国五矿,交易价格为606.76亿元。本次交易构成关联交易,不构成重大资产重组,已 达到股东会审议标准,需提交股东会审议批准。 0:00 ...
远东发展拟1亿澳元出售澳洲珀斯丽思卡尔顿酒店股权
Zheng Quan Shi Bao Wang· 2025-12-09 00:14
Core Viewpoint - Far East Development announced the sale of its stake in the Ritz-Carlton hotel operations and property company in Perth, Australia, for a total consideration of AUD 100 million (approximately HKD 515 million) to The Generation Essentials Group (NYSE: TGE) [2] Group 1 - The transaction aims to realize the value of the hotel, facilitate capital recycling, enhance the group's liquidity, and optimize its net asset-liability ratio [2] - The board believes that this sale aligns with the group's strategy to release profits from its hotel portfolio and divest non-core assets [2]
港股公告掘金 | 果下科技拟全球发售3385.29万股H股 引入惠开香港等基石投资者
Zhi Tong Cai Jing· 2025-12-08 15:25
Major Events - GuoXia Technology (02655) plans to conduct an IPO from December 8 to December 11, offering 33.85 million H-shares and introducing cornerstone investors such as Huikai Hong Kong [1] - Basilea Pharmaceutica AG (02616) has its drug Pujihua® (Pralsetinib Capsules) included in the National Medical Insurance Directory for 2025 [1] - Four Seasons Pharmaceutical (00460) sees its innovative drug XuanYueNing® included in the National Basic Medical Insurance Drug List for the first time [1] - Shanghai Pharmaceuticals (02607) successfully negotiates and includes Amisulpride Orally Disintegrating Tablets in the National Medical Insurance Directory [1] - Hansoh Pharmaceutical (03692) has its innovative drug Amelotex® approved for two new indications in the updated 2025 National Medical Insurance Directory [1] - Xiansheng Pharmaceutical (02096) sees EnzeShu® and EnDu® included in the updated National Medical Insurance Drug List [1] - Hutchison China MediTech (00013) has its drug Tazverik® included in the first edition of the National Commercial Health Insurance Innovative Drug List [1] - XuanZhu Biotechnology (02575) has its innovative drug XuanYueNing® included in the National Basic Medical Insurance Drug List for the first time [1] - Yino Pharmaceutical (02591) has its H-shares included in the list of eligible securities for the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect [1] - China Metallurgical Group (01618) and its subsidiaries plan to sell non-core business assets for approximately 60.68 billion yuan, focusing on core businesses in metallurgical engineering, non-ferrous metals, and mining engineering [1] - Cambridge Technology (06166) intends to invest a total of 405 million yuan to acquire and subscribe for shares in the Yangzhong Happiness Home Venture Capital Partnership Fund [1] Operating Performance - Dongfeng Motor Group (00489) reports cumulative automobile sales of 1.697 million units in the first 11 months, a year-on-year decrease of approximately 0.3% [2] - New天绿色能源 (00956) achieves a cumulative power generation of 1,336.89 million MWh in the first 11 months, an increase of 8.04% year-on-year [2] - Longyuan Power (00916) reports a cumulative power generation of approximately 6,909.64 million MWh in the first 11 months, a year-on-year growth of 0.41% [2] - Baolong Real Estate (01238) records a total contract sales of approximately 6.666 billion yuan in the first 11 months, a year-on-year decline of 43.2% [2]
远东发展(00035)拟1亿澳元出售澳洲珀斯丽思卡尔顿酒店的50%股权
智通财经网· 2025-12-08 13:08
Group 1 - The company announced a conditional sale agreement with The Generation Essentials Group for the sale of 50% of shares in two subsidiaries, RC Perth Operations Pty Ltd and Perth FEC Pty Ltd, for a total consideration of AUD 100 million (approximately HKD 515 million) [1] - The subsidiaries involved include an operational company primarily engaged in investment holding and a property company focused on property investment, both of which are wholly owned by the company [1] - The hotel in question is the Ritz-Carlton located at 1 Barrack St, Perth WA 6000, Australia [1] Group 2 - The board believes that the transaction will realize the value of the hotel, enable the reinvestment of proceeds, increase liquidity, and reduce the company's net asset liability ratio [2] - The transaction aligns with the company's strategy to release profits from its hotel portfolio and divest non-core assets [2]
英国石油(BP.US)就80亿美元出售嘉实多业务与Stonepeak深入谈判
Zhi Tong Cai Jing· 2025-12-05 12:44
Core Viewpoint - Stonepeak has emerged as a major competitor in the acquisition of BP's Castrol lubricants business, with negotiations centered around a bid valuing the business at over $8 billion [1] Group 1: Acquisition Details - BP put the Castrol lubricants business up for sale in February, with analysts initially estimating a potential sale price exceeding $10 billion [1] - The sale is part of BP's strategy to raise $20 billion through asset disposals by 2027, with the Castrol sale expected to contribute significantly to this target [1] - Initial bidders were deterred by the high price, but a deal at over $8 billion aligns with BP's current expectations [1] Group 2: Transaction Structure - Stonepeak may pursue a transaction structure similar to its recent acquisition of a majority stake in Phillips 66's subsidiary, where Phillips 66 retained a 35% minority stake [1] Group 3: Other Asset Sales - BP is also seeking buyers for a 50% stake in its Lightsource solar business, with expectations to raise $4 billion through asset disposals this year [1]